Ayurvedic Treatment for Uterine Fibroids

• Uterine fibroids — also called leiomyomas or myomas — are non-cancerous growths that develop in or on the uterus. They are the most common pelvic tumors in women, affecting up to 70–80% of women by age 50, according to research published in the American Journal of Obstetrics and Gynecology. Most fibroids cause no symptoms at all and are discovered incidentally during a routine ultrasound.
• But when they do cause problems — heavy menstrual bleeding, chronic pelvic pain, difficulty getting pregnant — the impact on daily life can be significant. This comprehensive guide covers everything from types and causes to the latest treatment options, recovery timelines, and emerging research, so you can make informed decisions about your health.

What Are Uterine Fibroids?

Uterine fibroids are firm, compact growths made of smooth muscle cells and fibrous connective tissue. They grow in and around the uterus, ranging in size from a tiny seedling invisible to the naked eye to bulky masses that can distort and enlarge the uterus. Some women have a single fibroid; others develop clusters of multiple fibroids of different sizes.

Despite how alarming the word "tumor" sounds, fibroids are almost always benign. The risk of a fibroid being cancerous (leiomyosarcoma) is less than 1 in 1,000 — and current evidence suggests that cancer does not develop from a pre-existing fibroid. It arises independently.

Where Do Fibroids Grow?

Fibroids can develop virtually anywhere in or on the uterus. Their location matters because it directly influences which symptoms you experience and which treatments are most effective.

Types of Uterine Fibroids by Location

What Do Fibroids Look Like?

On ultrasound or MRI, fibroids typically appear as smooth, round or oval, well-defined masses. During surgery, they are firm, pale (whitish-pink), and clearly distinct from surrounding uterine tissue. Pedunculated fibroids often have a characteristic mushroom-like or grape-on-a-stem appearance.

Clinical Classification by Size

While competitors often compare fibroids to fruits and everyday objects, a clearer clinical framework helps you understand your scan report:

• Doctors generally monitor small, asymptomatic fibroids.
• But size alone doesn't tell the whole story — a 2 cm submucosal fibroid can cause far more bleeding than a 7 cm subserosal one.

What Are the Symptoms of Uterine Fibroids?

• Many women with fibroids experience no symptoms whatsoever, and their fibroids are found incidentally during a pelvic exam or imaging study.
• When symptoms do occur, they typically include:

• Heavy or prolonged menstrual periods (menorrhagia) — soaking through a pad or tampon every hour for several consecutive hours
• Menstrual periods lasting longer than 7 days
• Pelvic pain or pressure — a persistent sense of fullness or heaviness in the lower abdomen
• Frequent urination — when fibroids press on the bladder
• Difficulty emptying the bladder
• Constipation or bloating — from pressure on the rectum
• Backache or leg pain
• Pain during intercourse (dyspareunia)
• Enlarged abdomen — sometimes mistaken for pregnancy or weight gain

What Does Uterine Fibroid Pain Feel Like?

• Fibroid-related pain is most often described as a dull, aching, or gnawing sensation in the lower abdomen, pelvis, or lower back.
• Some women experience sharp, stabbing pain — this can happen when a pedunculated fibroid twists on its stalk (torsion) or when a fibroid outgrows its blood supply and begins to degenerate. During menstruation, cramping can be significantly more intense than normal and may radiate down the thighs.

Which Size of Fibroid Is Dangerous?

• There's no single "dangerous" size. The real concern is the combination of size, location, rate of growth, and symptom severity.
• That said:

• Fibroids larger than 5 cm are more likely to cause noticeable symptoms.
• Rapidly growing fibroids — increasing more than 2–3 cm in 6 months — warrant closer investigation to rule out rare malignancies.
• Very large fibroids (>10 cm) can compress the ureters, potentially affecting kidney function, and may complicate pregnancy.

What Causes Uterine Fibroids?

The exact cause of uterine fibroids remains unclear, but research has identified several contributing factors.

Hormones. Estrogen and progesterone — the hormones that stimulate the uterine lining during each menstrual cycle — appear to promote fibroid growth. Fibroids contain more estrogen and progesterone receptors than normal uterine muscle cells. This is why fibroids tend to shrink after menopause, when hormone levels drop. Genetics. If your mother, sister, or grandmother had fibroids, your risk is significantly higher — approximately 2–3 times the average, according to data from WomensHealth.gov. Specific gene mutations (e.g., in the MED12 gene) have been found in fibroid cells. Extracellular matrix (ECM). Fibroids have an increased amount of ECM, which makes them fibrous and stiff. The ECM also stores growth factors that drive further cellular changes.

What Are Risk Factors for Uterine Fibroids?

• Age: Most commonly diagnosed in women aged 30–50; peak incidence in the 40s.
• Ethnicity: African American women develop fibroids 2–3 times more frequently and at younger ages, often with more severe symptoms. Researchers believe both genetic differences and the impact of systemic racism and social inequities in healthcare access contribute to these disparities.
• Obesity: Women with a BMI over 30 have a 2–3 times higher risk. Excess body fat increases circulating estrogen.
• Diet: Diets high in red meat and low in green vegetables, fruit, and dairy are associated with higher risk. A study in the International Journal of Environmental Research and Public Health (2021) found that higher vegetable intake correlated with lower fibroid incidence.
• Early menarche: Beginning menstruation before age 10 increases lifetime estrogen exposure.
• Vitamin D deficiency: Emerging evidence links low vitamin D levels with increased fibroid risk. A 2018 study in Fertility and Sterility found that women with sufficient vitamin D had a 32% lower risk of fibroids.
• Nulliparity: Women who have never given birth have a higher risk compared to those who have had children.

How Are Uterine Fibroids Diagnosed?

Fibroids are often discovered during a routine pelvic examination when a doctor feels irregularities in the shape of the uterus. Confirmatory imaging is then used to determine the number, size, and exact location of fibroids.

• Transvaginal or pelvic ultrasound — The first-line imaging test. A transducer is placed on the abdomen or inserted into the vagina to create images of the uterus.
• Saline sonohysterography (SIS) — Sterile saline is infused into the uterine cavity before ultrasound, making submucosal fibroids much easier to identify.
• MRI (Magnetic Resonance Imaging) — Provides the most detailed view. Especially useful before surgery or procedures like MRI-guided focused ultrasound. It can map every fibroid precisely.
• Hysteroscopy — A thin, lighted scope is inserted through the cervix into the uterus. Allows direct visualization of submucosal fibroids and can sometimes treat them during the same procedure.
• Hysterosonography / Hysterosalpingography (HSG) — Used particularly when evaluating fertility; shows whether fibroids are distorting the uterine cavity or blocking the fallopian tubes.
• CT scan — Less commonly used for fibroids but may identify them incidentally during imaging for other conditions.
• Laparoscopy — A minimally invasive surgical procedure where a camera is inserted through small abdominal incisions. Used diagnostically when other imaging is inconclusive.

Treatment for Uterine Fibroids: A Complete Guide

Treatment depends on your symptoms, fibroid size and location, your age, and whether you want to have children in the future. Not every fibroid needs treatment.

When Is Treatment Not Required?

If your fibroids are small, asymptomatic, and not growing rapidly, watchful waiting is a perfectly valid approach. This is especially true for women approaching menopause, since fibroids typically shrink once estrogen levels decline.

Watchful waiting protocol (what your doctor should monitor):

• Pelvic ultrasound every 6–12 months to track growth
• Regular blood counts to check for anemia
• Symptom journaling — track bleeding patterns, pain, urinary changes
• Red flags that should trigger re-evaluation: rapid growth (>2 cm in 6 months), new or worsening symptoms, hemoglobin dropping below 10 g/dL

Medications for Uterine Fibroids

Medications don't eliminate fibroids but can control symptoms and, in some cases, temporarily shrink them.

Hormonal Contraceptives

Birth control pills, patches, and hormonal IUDs (like the levonorgestrel-releasing IUD) can reduce heavy menstrual bleeding. They don't shrink fibroids but can make symptoms very manageable for many women.

GnRH Agonists (e.g., Leuprolide)

These medications create a temporary, reversible menopause-like state by suppressing estrogen production. Fibroids may shrink by 30–50% over 3–6 months. Due to side effects (hot flashes, bone loss), they're typically used short-term — often before surgery to reduce fibroid size and make the procedure easier.

Add-back therapy: To counter menopausal side effects, doctors often prescribe low-dose estrogen and progestin alongside GnRH agonists. This approach preserves the fibroid-shrinking benefit while significantly reducing hot flashes and protecting bone density.

GnRH Antagonists (e.g., Elagolix, Relugolix combination therapy)

Newer oral medications that work similarly to GnRH agonists but with a faster onset and easier administration. Relugolix combination therapy (Myfembree), approved by the FDA in 2021, combines a GnRH antagonist with estradiol and norethindrone acetate — essentially building add-back therapy right into the pill. Clinical trials showed a 73% reduction in heavy menstrual bleeding at 24 weeks.

Tranexamic Acid

A non-hormonal medication taken during menstruation to reduce heavy bleeding. It works by helping blood clot more effectively. It doesn't affect fibroid size or hormones, making it an option for women who prefer to avoid hormonal treatment.

Iron Supplements

Not a treatment for fibroids per se, but essential for managing anemia caused by chronic heavy bleeding. Your doctor may recommend oral iron supplements or, in severe cases, intravenous iron infusion.

Minimally Invasive Procedures

This is an area where competitors provide surprisingly little detail, so let's go deeper.

Uterine Artery Embolization (UAE)

A radiologist threads a thin catheter through the femoral artery in the groin and injects small particles (polyvinyl alcohol or gel beads) into the uterine arteries feeding the fibroids. This blocks their blood supply, causing the fibroids to shrink — typically by 40–60% over 3–6 months.

• Recovery: 1–2 weeks (vs. 4–6 weeks for open surgery)
• Effectiveness: 85–90% of women report significant symptom improvement
• Fertility consideration: Generally not the first choice for women planning pregnancy, though successful pregnancies have been reported after UAE. Some studies suggest slightly higher rates of miscarriage and placental complications.

MRI-Guided Focused Ultrasound Surgery (MRgFUS / HIFU)

A completely non-invasive approach. High-intensity focused ultrasound waves are directed at the fibroid while MRI provides real-time imaging guidance. The concentrated sound waves generate heat that destroys fibroid tissue.

• Recovery: Most women return to normal activities within 1–2 days
• Effectiveness: Best for 1–3 fibroids that are clearly accessible; results vary based on fibroid characteristics
• Limitations: Not suitable for all fibroid types, locations, or sizes; limited long-term data on recurrence

Radiofrequency Ablation (RFA / Acessa Procedure)

A laparoscopic needle device is inserted into each fibroid and delivers radiofrequency energy, heating and destroying the tissue from the inside out. The fibroid gradually shrinks as the body reabsorbs the treated tissue.

• Recovery: 3–5 days typically
• Effectiveness: Studies show 40–70% volume reduction and significant symptom improvement in most patients
• Fertility: Emerging data suggests it may preserve fertility better than traditional myomectomy, but more research is needed

Surgical Treatments

Myomectomy (Fibroid Removal, Uterus Preserved)

• Recurrence after myomectomy is a reality that many sources fail to mention. Studies indicate that 20–30% of women experience fibroid recurrence within 5 years of myomectomy, and approximately 10% require re-intervention.
• This doesn't mean myomectomy isn't worthwhile — it absolutely is, especially for women who want to preserve fertility — but it's important to have realistic expectations.

Hysterectomy (Uterus Removal)

The only definitive cure for uterine fibroids. Once the uterus is removed, fibroids cannot recur. Hysterectomy can be performed abdominally, laparoscopically, vaginally, or with robotic assistance. It may include removal of the cervix (total hysterectomy) or leave the cervix in place (supracervical hysterectomy). The ovaries are usually preserved in premenopausal women to avoid surgical menopause.

Recovery: 2–6 weeks depending on approach. Vaginal and laparoscopic approaches generally allow faster recovery.

• This is a permanent decision.
• It's the right choice for many women — particularly those with severe symptoms who have completed childbearing — but it eliminates the possibility of future pregnancy.

Uterine Fibroids, Fertility, and Pregnancy

Can you get pregnant with fibroids? Yes, many women with fibroids conceive naturally and have uncomplicated pregnancies. However, fibroids can affect fertility and pregnancy in several ways:

Impact on Fertility

• Submucosal fibroids are the most problematic — they can distort the uterine cavity, interfere with embryo implantation, and block the fallopian tubes.
• Large intramural fibroids (>4–5 cm) may also reduce implantation rates.
• Subserosal fibroids generally don't affect fertility unless they're very large.

Complications During Pregnancy

• Increased risk of cesarean delivery — fibroids can obstruct the birth canal or cause abnormal fetal positioning
• Breech presentation — fibroids may prevent the baby from turning head-down
• Placental abruption — particularly if the placenta attaches near a fibroid
• Preterm delivery — some studies show a modest increase in preterm birth risk
• Fibroid degeneration — during pregnancy, a rapidly growing fibroid may outgrow its blood supply, causing sudden, severe pain (typically managed with pain medication and rest)

If you're planning pregnancy and have fibroids, discuss the specific location and size with your gynecologist. In some cases, pre-pregnancy myomectomy may improve outcomes.

Impact on Quality of Life and Mental Health

This is something that medical sources rarely address, but women living with symptomatic fibroids consistently report. The burden goes far beyond physical symptoms.

• Work and productivity: A survey published in the Journal of Women's Health (2013) found that women with symptomatic fibroids missed an average of 3.5 more workdays per year and reported significantly reduced productivity due to pain and heavy bleeding.
• Anxiety and depression: Chronic pain, unpredictable heavy bleeding, and fear of "accidents" in public can lead to significant anxiety. Studies show that women with fibroids have higher rates of depression compared to age-matched controls.
• Sexual health: Pain during intercourse, heavy bleeding, and an enlarged abdomen can negatively affect intimacy and body image.
• Social isolation: Some women avoid travel, social events, and exercise during their periods due to fear of uncontrollable bleeding.

These impacts are real and valid. If fibroids are affecting your mental health, it's worth discussing with your doctor — sometimes treatment is justified not just for physical symptoms, but for overall wellbeing.

Do Uterine Fibroids Go Away? Can Fibroids Be Cured?

• Fibroids do not typically disappear on their own during the reproductive years.
• However:

• After menopause, fibroids usually shrink significantly due to the natural decline in estrogen and progesterone. Many women become asymptomatic.
• Medications can temporarily shrink fibroids (GnRH agonists/antagonists), but they often regrow once medication is stopped.
• Myomectomy removes existing fibroids but doesn't prevent new ones from forming (recurrence rate: up to 30% within 5 years).
• Hysterectomy is the only permanent cure — no uterus, no fibroids.

Emerging Natural and Complementary Approaches

While no natural remedy has been proven to cure fibroids, some research is worth noting:

• Vitamin D supplementation: A 2019 randomized controlled trial in Fertility and Sterility found that women who took vitamin D supplements experienced slowed fibroid growth compared to placebo. This is particularly relevant for women with documented deficiency.
• EGCG (green tea extract): A 2013 study published in the International Journal of Women's Health showed that epigallocatechin gallate (EGCG) reduced fibroid volume by 32.6% over 4 months, compared to a 24.3% increase in the placebo group. Promising, but larger trials are needed.
• Curcumin (turmeric extract): Laboratory studies suggest curcumin may inhibit fibroid cell proliferation, but robust human clinical trials are still lacking.

These should complement, not replace conventional medical care. Always discuss supplements with your doctor, especially if you're taking other medications.

Latest Research and Clinical Trials (2023–2025)

• The fibroid treatment landscape is evolving.
• Here's what's on the horizon:

• Relugolix combination therapy — Now approved and being studied in longer-term trials for extended use beyond 24 months.
• Selective progesterone receptor modulators (SPRMs): Ulipristal acetate showed promise but was limited by liver safety concerns. Newer SPRMs are in development with improved safety profiles.
• Injectable GnRH antagonists: Linzagolix, an oral GnRH antagonist, showed positive results in Phase III trials published in 2023, with flexible dosing options.
• Improved radiofrequency ablation devices: Next-generation transcervical fibroid ablation (Sonata system) allows fibroid treatment through the cervix with no abdominal incisions, guided by real-time ultrasound.
• Gene therapy and targeted molecular approaches: Early-stage research is exploring ways to target the specific genetic mutations (MED12, HMGA2) that drive fibroid growth. Still years from clinical application, but a fundamentally different approach.

Frequently Asked Questions (FAQ)

Can I live with uterine fibroids?

Absolutely. Most women with fibroids live completely normal lives, especially when fibroids are small and asymptomatic. Even with symptoms, many women manage effectively with medication or lifestyle modifications. Treatment is recommended when fibroids cause significant bleeding, pain, anemia, fertility issues, or affect your quality of life.

Are uterine fibroids dangerous?

• In the vast majority of cases, no. Fibroids are benign and not life-threatening. However, they can cause severe anemia from chronic heavy bleeding (which can become dangerous if untreated), and very large fibroids can occasionally compress the ureters and affect kidney function.
• The risk of a fibroid being cancerous is extremely low — less than 0.1%.

Can fibroids turn into cancer?

Current medical evidence indicates that benign fibroids do not transform into cancer. Leiomyosarcoma (uterine cancer that resembles fibroids) is a separate condition that arises independently. It is very rare.

What questions should I ask my doctor?

If you've been diagnosed with fibroids, consider asking:

• How many fibroids do I have, and what are their sizes and locations?
• Are they likely to grow? How fast?
• Do I need treatment now, or can we monitor them?
• Which treatment options preserve my fertility?
• What are the risks and benefits of each approach?
• How long is recovery, and when can I return to work?
• What symptoms should prompt me to come back sooner?

What is the ICD-10 code for uterine fibroids?

The ICD-10 code for uterine leiomyoma is D25. Subtypes include D25.0 (submucous), D25.1 (intramural), D25.2 (subserosal), and D25.9 (unspecified).

Take Control of Your Fibroid Journey

• Uterine fibroids are incredibly common, and having them does not mean you're destined for surgery or a life of suffering.
• The right treatment — or the decision to simply monitor — depends on your unique situation: your symptoms, your fibroid characteristics, your fertility goals, and your personal preferences.

• Start by getting a proper diagnosis with imaging. Understand your options. Don't hesitate to seek a second opinion, especially before any surgical decision.
• And remember — the goal isn't just to treat fibroids; it's to restore your quality of life.

If you're experiencing symptoms that might be related to fibroids — heavy periods, pelvic pressure, unexplained bloating — schedule an appointment with a gynecologist. Early evaluation gives you the most options and the best outcomes.

Scientific Sources

1. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT — Daniels J et al., 2022, Health technology assessment (Winchester, England)
2. Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis — Saad EE et al., 2024, Cytokine & growth factor reviews
3. Herbal preparations for uterine fibroids — Liu JP et al., 2013, The Cochrane database of systematic reviews
4. Herbal preparations for uterine fibroids — Liu JP et al., 2009, The Cochrane database of systematic reviews
5. Insomnia and Female Reproductive Diseases: A Cross-Sectional and Mendelian Randomization Study — Fang L et al., 2025, International journal of women's health
6. Medical therapy for fibroids: An overview — Sinai Talaulikar V, 2018, Best practice & research. Clinical obstetrics & gynaecology
7. Acupuncture for uterine fibroids — Zhang Y et al., 2010, The Cochrane database of systematic reviews
8. The efficacy and safety of Chinese herbal medicine Guizhi Fuling capsule combined with low dose mifepristone in the treatment of uterine fibroids: a systematic review and meta-analysis of 28 randomized controlled trials — Lei Y et al., 2023, BMC complementary medicine and therapies
9. Causal association between uterine fibroids and cardiovascular disease: A Mendelian randomization study — Yao M et al., 2025, Medicine
10. Androgen Signaling in Uterine Diseases: New Insights and New Targets — Lv M et al., 2022, Biomolecules
11. Minimally invasive and ablative therapies for symptomatic uterine fibroids: a narrative review — Gemesi TS et al., 2025, Current opinion in obstetrics & gynecology
12. Update on Endovascular Therapy for Fibroids and Adenomyosis — Ozen M et al., 2023, Seminars in interventional radiology
13. Efficacy of Chinese herbal prescriptions containing Ejiao or Velvet antler for management of uterine fibroids: a systematic review and meta-analysis of randomized controlled trials — Li Q et al., 2021, Annals of palliative medicine
14. The efficacy and safety of Chinese herbal medicine Shugan Sanjie decoction in the treatment of uterine fibroids: a systematic review and meta-analysis — Zhang Y et al., 2025, Frontiers in pharmacology
15. Psychological distress and uterine fibroids: a bidirectional two-sample mendelian randomization study — Han X et al., 2024, BMC women's health
16. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy — Guarnaccia MM et al., 2001, Clinical obstetrics and gynecology
17. Integrated pharmacoanalysis, bioinformatics analysis, and experimental validation to identify the ingredients and mechanisms of Xiao-Luo-Wan in uterine fibroids treatment — Yu Y et al., 2025, Pharmaceutical biology
18. Chinese herbal medicine Guizhi Fuling Formula for treatment of uterine fibroids: a systematic review of randomised clinical trials — Chen NN et al., 2014, BMC complementary and alternative medicine
19. Review of nonsurgical/minimally invasive treatments and open myomectomy for uterine fibroids — Chittawar PB et al., 2015, Current opinion in obstetrics & gynecology
20. Uterine Artery Embolization: A Growing Pillar of Gynecological Intervention — Balamurugan S et al., 2025, Journal of radiology and clinical imaging